Management

Susan Josi, Managing Partner, Sorento Healthcare, gives an insight on why healthcare companies must build new models of innovation…

Phanish Chandra, CEO and Co-founder, Docplexus Online Services in this insight article gives an overview of about the relevance of…

Japan will see the most impressive relative growth, with sales expanding from $47 million in 2014 to $268 million in 2024

Leena Menghaney, Regional Head, MSF Access Campaign, South Asia, in this article, explores milestones in policies that have had an…

Spurring the growth of biosimilars is the need to improve access to biologics and contain treatment costs and healthcare budgets,…

The increase represents a tepid CAGR of 1.52 per cent across Argentina and the seven major markets of the US, France, Italy,…

The Government was supposed to launch a policy for the ‘Jan Aushadhi Scheme’ in September 15. However, it has been delayed due to…

The growth will primarily be driven by the continued uptake of premium products and an increase in treatment rates as a result of…

The increase will be boosted by increasing therapeutic options, including the introduction of two monoclonal antibodies with…

The treatment landscape is expected to experience a paradigm shift towards integrase inhibitor drugs and single-tablet regimens